We really can't promise both more transplants and better outcomes. The controversies over organ allocation really represent intellectual exhaustion in the face of a long series of inadequate policy responses to the decade-long trend of the kidney supply increasing only at the expense of organ quality and patient outcomes.

Burn care physicians must walk a fine line between providing individualized care and applying population-based quality metrics.

The organ transplantation system is viewed as one of our most equitable health care services, but poor patients are effectively excluded by policy that denies Medicaid coverage of post-transplant immunosuppressant medication.

Shackling incarcerated surgery patients is unnecessary for safety and undermines patients’ trust.

Physicians are responsible for overseeing and collaborating with the expanded health care delivery team.

Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit.

Transgender people planning a medical transition face decisions about family planning, fertility preservation, and how to access gender-affirming treatment.

Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications.

The benefits of the international presumed-consent policy are presented as a solution to the United States' current shortage of organs available for transplantation.

Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities.